2. Academic Validation
  3. Cirsiliol regulates mitophagy in colon cancer cells via STAT3 signaling

Cirsiliol regulates mitophagy in colon cancer cells via STAT3 signaling

  • Cancer Cell Int. 2022 Oct 7;22(1):304. doi: 10.1186/s12935-022-02732-6.
Tao Jiang 1 2,  Lulu Peng 2,  Qian Wang 2,  Bingyu Huang 2,  Dewei Peng 2,  Lintong Men 2,  Yue Jiang 2,  Mengying Zhu 2,  Moran Wang 2,  Li Lin 2,  Jiagao Lv 3,  Sheng Li 4
Affiliations

Affiliations

  • 1 Department of Geriatrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • 2 Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, P.O. Box 430030, Wuhan, People's Republic of China.
  • 3 Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, P.O. Box 430030, Wuhan, People's Republic of China. [email protected].
  • 4 Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Jiefang Avenue 1095, P.O. Box 430030, Wuhan, People's Republic of China. [email protected].
PMID: 36207761 DOI: 10.1186/s12935-022-02732-6
Abstract

Background: Mitophagy is a type of selective Autophagy for dysfunctional mitochondria and plays a key role in tumorigenesis and Cancer progression. However, whether Mitophagy plays a role in colon Cancer remains unclear. Cirsiliol is a natural product and has been found to exert anti-cancer effects in multiple tumors. The effects of cirsiliol in the tumorigenesis and progression of colon Cancer remain unknown.

Methods: CCK8 assay, plate cloning assay, and cell scratch assay were performed to determine cell viability, colony formation, and wound healing abilities of HCT116 and SW480 cells. JC-1 staining, H2DCFDA staining, and Mito-Tracker Red staining were carried out to evaluate mitochondrial membrane potential (Δψm), intracellular Reactive Oxygen Species (ROS) level, and mitochondrial morphology. Molecular docking technology was utilized to predict interaction of cirsiliol and signal transducer and activator of transcription 3 (STAT3). Immunofluorescence staining was used to measure nuclear translocation of STAT3. The protein levels of phosphorylated STAT3 (Y705), total STAT3, and Mitophagy proteins were detected by western blot.

Results: In this study, we first found that cirsiliol inhibited cell viability, colony formation, and wound healing abilities of HCT116 and SW480 colon Cancer cells. Moreover, cirsiliol suppressed Δψm, increased ROS production, and disrupted mitochondrial morphology via inhibiting the levels of Mitophagy proteins including PINK1, Parkin, BNIP3, and FUNDC1. Application of Mitophagy Activator improved the levels of mitophagy-related proteins, and ameliorated Δψm and ROS levels. According to the result of molecular docking, we found that cirsiliol potentially bound to the SH2 domain of STAT3, the key domain for the functional activation of STAT3. Moreover, it was found that cirsiliol inhibited constitutive and IL‑6‑induced STAT3 phosphorylation and nuclear translocation by western blot and immunofluorescence analysis. Comparing with cirsiliol group, we found that overexpression of STAT3 restored the expressions of Mitophagy proteins.

Conclusions: Cirsiliol targets STAT3 to inhibit colon Cancer cell proliferation by regulating Mitophagy.

Keywords

Cirsiliol; Colon cancer; Mitophagy; ROS; STAT3.

Figures
Products
Inhibitors & Agonists
Other Products